ATE302013T1 - Azithromycin enthaltende zusammensetzungen zur kontrolle von emesis bei hunden - Google Patents
Azithromycin enthaltende zusammensetzungen zur kontrolle von emesis bei hundenInfo
- Publication number
- ATE302013T1 ATE302013T1 AT99309405T AT99309405T ATE302013T1 AT E302013 T1 ATE302013 T1 AT E302013T1 AT 99309405 T AT99309405 T AT 99309405T AT 99309405 T AT99309405 T AT 99309405T AT E302013 T1 ATE302013 T1 AT E302013T1
- Authority
- AT
- Austria
- Prior art keywords
- dogs
- compositions containing
- macrolide antibiotic
- containing azithromycin
- antagonist
- Prior art date
Links
- 206010047700 Vomiting Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title 1
- 229960004099 azithromycin Drugs 0.000 title 1
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 3
- 239000003890 substance P antagonist Substances 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000028172 protozoa infectious disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11787699P | 1999-01-29 | 1999-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE302013T1 true ATE302013T1 (de) | 2005-09-15 |
Family
ID=22375307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99309405T ATE302013T1 (de) | 1999-01-29 | 1999-11-25 | Azithromycin enthaltende zusammensetzungen zur kontrolle von emesis bei hunden |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20020016301A1 (de) |
| EP (1) | EP1027892B1 (de) |
| JP (1) | JP2000219640A (de) |
| KR (1) | KR20000052444A (de) |
| AT (1) | ATE302013T1 (de) |
| AU (1) | AU6065799A (de) |
| CA (1) | CA2290771A1 (de) |
| DE (1) | DE69926722D1 (de) |
| HU (1) | HUP9904393A2 (de) |
| IL (1) | IL133077A0 (de) |
| NZ (1) | NZ501211A (de) |
| ZA (1) | ZA997288B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL151888A0 (en) * | 2000-03-28 | 2003-04-10 | Biochemie Gmbh | Granulated particles with masked taste |
| GB0315671D0 (en) * | 2003-07-04 | 2003-08-13 | Chelsea And Westminster Nhs Tr | Improvements in or relating to organic compounds |
| EP2029147B1 (de) * | 2006-06-12 | 2010-05-19 | Ramot at Tel-Aviv University Ltd. | Verfahren zur behandlung von krebs |
| EP2340254B8 (de) | 2008-09-15 | 2014-05-21 | Biovista, Inc. | Zusammensetzungen und verfahren zur behandlung von epilepsie |
| US9795601B2 (en) * | 2010-12-15 | 2017-10-24 | Biovista, Inc. | Compositions and methods for cancer treatment |
| US20150018362A1 (en) | 2012-02-27 | 2015-01-15 | Biovista, Inc. | Compositions and methods for treating mitochondrial diseases |
| KR20230155155A (ko) * | 2022-05-03 | 2023-11-10 | 녹십자수의약품 주식회사 | 마크로라이드 계열 항생제를 유효성분으로 포함하는 개과 동물의 호흡기 질환의 예방 또는 치료용 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4833236A (en) * | 1986-05-02 | 1989-05-23 | Taisho Pharmaceutical Co., Ltd. | Erythromycin derivatives |
| ATE195867T1 (de) * | 1991-09-20 | 2000-09-15 | Glaxo Group Ltd | Neue medizinische indikation für tachykinin- antagonisten |
| MX9308001A (es) * | 1992-12-21 | 1994-08-31 | Lilly Co Eli | Premezcla para piensos de animales que contiene tilosina y procedimiento para su obtencion. |
| GB9305718D0 (en) * | 1993-03-19 | 1993-05-05 | Glaxo Group Ltd | Medicaments |
| US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
| FR2740335B1 (fr) * | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p |
| CA2189501A1 (en) * | 1995-11-06 | 1997-05-07 | Harry R. Howard | Nk-1 receptor antagonists for the treatment of cancer |
| US5958888A (en) * | 1996-07-02 | 1999-09-28 | Merial, Inc. | Water miscible macrolide solutions |
-
1999
- 1999-11-22 IL IL13307799A patent/IL133077A0/xx unknown
- 1999-11-22 NZ NZ501211A patent/NZ501211A/en unknown
- 1999-11-23 HU HU9904393A patent/HUP9904393A2/hu unknown
- 1999-11-24 ZA ZA9907288A patent/ZA997288B/xx unknown
- 1999-11-25 AU AU60657/99A patent/AU6065799A/en not_active Abandoned
- 1999-11-25 DE DE69926722T patent/DE69926722D1/de not_active Expired - Lifetime
- 1999-11-25 EP EP99309405A patent/EP1027892B1/de not_active Expired - Lifetime
- 1999-11-25 AT AT99309405T patent/ATE302013T1/de not_active IP Right Cessation
- 1999-11-26 CA CA002290771A patent/CA2290771A1/en not_active Abandoned
- 1999-11-26 JP JP11336551A patent/JP2000219640A/ja active Pending
- 1999-12-09 KR KR1019990056111A patent/KR20000052444A/ko not_active Ceased
-
2001
- 2001-08-15 US US09/929,899 patent/US20020016301A1/en not_active Abandoned
-
2002
- 2002-08-22 US US10/226,994 patent/US20030018049A1/en not_active Abandoned
-
2003
- 2003-09-18 US US10/666,908 patent/US20040063649A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20030018049A1 (en) | 2003-01-23 |
| AU6065799A (en) | 2000-08-03 |
| NZ501211A (en) | 2001-10-26 |
| CA2290771A1 (en) | 2000-07-29 |
| ZA997288B (en) | 2001-05-24 |
| HUP9904393A2 (en) | 2002-09-28 |
| US20020016301A1 (en) | 2002-02-07 |
| EP1027892B1 (de) | 2005-08-17 |
| IL133077A0 (en) | 2001-03-19 |
| HU9904393D0 (en) | 2000-01-28 |
| DE69926722D1 (de) | 2005-09-22 |
| EP1027892A2 (de) | 2000-08-16 |
| JP2000219640A (ja) | 2000-08-08 |
| KR20000052444A (ko) | 2000-08-25 |
| EP1027892A3 (de) | 2002-06-19 |
| US20040063649A1 (en) | 2004-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9714269A (pt) | Composto, composição farmacêutica, e, processos para controlar uma infecção bacteriana em um mamìfero e para a preparação de compostos macrólidos tricìclicos | |
| PE20001112A1 (es) | Derivados de quinolina como agentes antibacterianos | |
| GEP20053429B (en) | 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents | |
| BR9510423A (pt) | Formulação lipossomal multilamelar de baixa rigidez processo de tratamento ou de profilaxia de uma infecção bacteriana em um animal e de uma variante mucoìde da mesma, uso da formulação lipossomal antibacteriana | |
| MY131300A (en) | Antibacterial agents | |
| EP1171428A4 (de) | Fab-i inhibitoren | |
| DE69315839D1 (de) | Derivate von 16-gliedrigen antibiotischen macroliden | |
| ATE302013T1 (de) | Azithromycin enthaltende zusammensetzungen zur kontrolle von emesis bei hunden | |
| MX9708611A (es) | Compuestos de dialquiltiacumicina. | |
| EP0708770A1 (de) | Amid-derivate von 16-gliedrige heterocyclen als antibiotische macrolide | |
| HU9403502D0 (en) | 9 a-n-(n`-carbamoyl) and 9 a-n-(n`-thiocarbamoyl) derivatives 9-deoxo-9a-aza-9a-homoerythro-mycin a | |
| MD1788G2 (ro) | Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase | |
| DK0560613T3 (da) | Antimikrobielle carbapenemderivater, deres fremstilling og deres terapeutiske anvendelse | |
| FI101978B1 (fi) | Menetelmä leustroduksiinien valmistamiseksi | |
| WO1990006307A3 (en) | Antibacterial quinolone compounds | |
| EP1227721A4 (de) | Neue substituierte bernsteinsäure metall-beta-lactamase-inhibitoren und ihre verwendung zur behandlung von bakteriellen infektionen | |
| DE3775823D1 (de) | Pharmazeutische zubereitung zur behandlung bakterieller infektionen. | |
| BR0308734A (pt) | Composto, composição farmacêutica, uso do composto, e, método para prevenir ou tratar infecção | |
| BR0115719A (pt) | Inibição de produção de exoproteìna de bactéria gram-positiva | |
| NO20042711L (no) | Fremgangsmate for a behandle bakterielle infeksjoner ved anvendelse av gemifloksasin eller et salt derav et betalaktamantibiotikum | |
| ES8707955A1 (es) | Un procedimiento para la preparacion pirazolidinonas biciclicas' | |
| DE69024141D1 (de) | Chemische Derivate von Antbiotika LL-E19020 alpha und beta | |
| TR199701286T1 (xx) | Karbapenemlerin esterleri. | |
| IL83626A (en) | Macrolide antibiotic, swalpamycin, a microbiological process for its preparation and pharmaceutical compositions containing same | |
| ZA901320B (en) | Compositions for the treatment of microbial infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |